ArticleScientific reports2017

Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus.

Martina Guthoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.